Da Hee Han, PharmD

Most Recent Articles by Da Hee Han, PharmD

Fresenius Kabi Adds Additional Strengths to Adenosine Product Line

Fresenius Kabi Adds Additional Strengths to Adenosine Product Line

By

Adenosine Injection, a pharmacologic stress agent, is indicated as an adjunct to thallium-201 myocardial perfusion scintigraphy in patients unable to exercise adequately.

Calcium Channel Blocker May Benefit Patients With Type 1 Diabetes

Calcium Channel Blocker May Benefit Patients With Type 1 Diabetes

By

For this study, researchers conducted a randomized, double-blind, placebo-controlled Phase 2 trial (N=24) to assess the efficacy and safety of adding oral verapamil for 12 months to a standard insulin regimen in adults with recent-onset type 1 diabetes (age range: 18 to 45 years).

Blister Packs for Several Meds Recalled Due to Risk of Harm to Children

Blister Packs for Several Meds Recalled Due to Risk of Harm to Children

By

The recall affects approximately 470,000 units that include drugs packaged with 3 to 10 tablets per blister card. The blister packs were developed for use in hospitals, however some were sent to retail pharmacies and were likely dispensed for in-home use.

Atypical Antipsychotic Use and CV Events in Youth: What's the Link?

Atypical Antipsychotic Use and CV Events in Youth: What's the Link?

By

The retrospective cohort study involved a search of Medicaid claims of pediatric patients aged 5 to 20 years who were initiated on atypical antipsychotic medications.

Rivaroxaban Use in Older Patients: Does Age Influence Safety, Efficacy?

Rivaroxaban Use in Older Patients: Does Age Influence Safety, Efficacy?

By

Data from large Phase 3 studies showed that treatment with rivaroxaban was found to be safe and effective in older patients.

More Articles by Da Hee Han, PharmD

Sign Up for Free e-Newsletters